Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma

被引:1
作者
Cheng, Guangyang [1 ]
Zhou, Zhaokai [1 ,2 ,3 ]
Li, Shiqi [1 ]
Ye, Zhuo [1 ]
Wang, Yan [1 ]
Wen, Jianguo [1 ,2 ,3 ]
Ren, Chuanchuan [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Henan Joint Int Pediat Urodynam Lab, Zhengzhou 450052, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Bladder Struct & Funct Reconstruct Henan Engn Lab, Zhengzhou 450052, Henan, Peoples R China
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2024年 / 21卷 / 11期
基金
中国国家自然科学基金;
关键词
Proteomics; Transcriptomics; Renal clear cell carcinoma; Prognostic signature; tumor microenvironment; CANCER; P21; IDENTIFICATION; EFFICACY; RPS6KB1;
D O I
10.7150/ijms.99992
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Protein information is often replaced by RNA data in studies to understand cancer-related biological processes or molecular functions, and proteins of prognostic significance in Kidney clear cell carcinoma (KIRC) remain to be mined. Methods: The cancer genome atlas program (TCGA) data was utilized to screen for proteins that are prognostically significant in KIRC. Machine learning algorithms were employed to develop protein immunotherapeutic responses were analyzed in various protein risk subgroups. Ultimately, the validation of protein-coding genes was confirmed by utilizing an online database and implementing quantitative Results: The patients were divided into two risk categories based on prognostic proteins, and notable disparities in both overall survival (OS) and progression free interval (PFI) were observed between the two groups. The OS was more unfavorable in the high-risk group, and there was a noteworthy disparity in the level of immune infiltration observed between the two groups. In addition, the nomogram showed high accuracy in predicting survival in KIRC patients. Conclusion: In this research, we elucidated the core proteins associated with prognosis in terms of survival prediction, immunotherapeutic response, somatic mutation, and immune microenvironment. Additionally, we have developed a reliable prognostic model with excellent predictive capabilities.
引用
收藏
页码:2215 / 2232
页数:18
相关论文
共 50 条
[31]   Systemic Light Chain Amyloidosis, Version 2.2023 [J].
Kumar, Shaji K. ;
Callander, Natalie S. ;
Adekola, Kehinde ;
Anderson, Larry D., Jr. ;
Baljevic, Muhamed ;
Campagnaro, Erica ;
Castillo, Jorge J. ;
Costello, Caitlin ;
D'Angelo, Christopher ;
Devarakonda, Srinivas ;
Elsedawy, Noura ;
Garfall, Alfred ;
Godby, Kelly ;
Hillengass, Jens ;
Holmberg, Leona ;
Htut, Myo ;
Huff, Carol Ann ;
Hultcrantz, Malin ;
Kang, Yubin ;
Larson, Sarah ;
Lee, Hans C. ;
Liedtke, Michaela ;
Martin, Thomas ;
Omel, James ;
Rosenberg, Aaron ;
Sborov, Douglas ;
Valent, Jason ;
Berardi, Ryan ;
Kumar, Rashmi .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01) :67-81
[32]   Quantitative Proteomics of the Cancer Cell Line Encyclopedia [J].
Nusinow, David P. ;
Szpyt, John ;
Ghandi, Mahmoud ;
Rose, Christopher M. ;
McDonald, E. Robert, III ;
Kalocsay, Marian ;
Jane-Valbuena, Judit ;
Gelfand, Ellen ;
Schweppe, Devin K. ;
Jedrychowski, Mark ;
Golji, Javad ;
Porter, Dale A. ;
Rejtar, Tomas ;
Wang, Y. Karen ;
Kryukov, Gregory, V ;
Stegmeier, Frank ;
Erickson, Brian K. ;
Garraway, Levi A. ;
Sellers, William R. ;
Gygil, Steven P. .
CELL, 2020, 180 (02) :387-+
[33]   SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis [J].
Pandey, Swaroop Kumar ;
Paul, Avijit ;
Shteinfer-Kuzmine, Anna ;
Zalk, Ran ;
Bunz, Uwe ;
Shoshan-Barmatz, Varda .
MOLECULAR ONCOLOGY, 2021, 15 (11) :3037-3061
[34]   Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression [J].
Park, Jihyun ;
Tacam, Moises J. ;
Chauhan, Gaurav ;
Cohen, Evan N. ;
Gagliardi, Maria ;
Iles, Lakesla R. ;
Ueno, Naoto T. ;
Battula, Venkata L. ;
Sohn, Yoo-Kyoung ;
Wang, Xiaoping ;
Kim, Hak-Sung ;
Krishnamurthy, Savitri ;
Fowlkes, Natalie W. ;
Green, Morgan M. ;
Bartholomeusz, Geoffrey A. ;
Tripathy, Debu ;
Reuben, James M. ;
Bartholomeusz, Chandra .
BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) :333-345
[35]   Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma [J].
Peng, Jiang-Yun ;
Cai, Dian-Kui ;
Zeng, Ren-Li ;
Zhang, Chao-Yang ;
Li, Guan-Cheng ;
Chen, Si-Fan ;
Yuan, Xiao-Qing ;
Peng, Li .
ADVANCED SCIENCE, 2023, 10 (01)
[36]   A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population [J].
Qu, Yuanyuan ;
Feng, Jinwen ;
Wu, Xiaohui ;
Bai, Lin ;
Xu, Wenhao ;
Zhu, Lingli ;
Liu, Yang ;
Xu, Fujiang ;
Zhang, Xuan ;
Yang, Guojian ;
Lv, Jiacheng ;
Chen, Xiuping ;
Shi, Guo-Hai ;
Wang, Hong-Kai ;
Cao, Da-Long ;
Xiang, Hang ;
Li, Lingling ;
Tan, Subei ;
Gan, Hua-Lei ;
Sun, Meng-Hong ;
Qiu, Jiange ;
Zhang, Hailiang ;
Zhao, Jian-Yuan ;
Ye, Dingwei ;
Ding, Chen .
NATURE COMMUNICATIONS, 2022, 13 (01)
[37]   Chalepin: isolated from Ruta angustifolia L. Pers induces mitochondrial mediated apoptosis in lung carcinoma cells [J].
Richardson, Jaime Stella Moses ;
Sethi, Gautam ;
Lee, Guan Serm ;
Malek, Sri Nurestri Abdul .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 16
[38]   Cancer proteomics [J].
Tan, Hwee Tong ;
Lee, Yie Hou ;
Chung, Maxey C. M. .
MASS SPECTROMETRY REVIEWS, 2012, 31 (05) :583-605
[39]   Lipids as Targets for Renal Cell Carcinoma Therapy [J].
Tanturovska, Bisera Stepanovska ;
Manaila, Roxana ;
Fabbro, Doriano ;
Huwiler, Andrea .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
[40]   Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma [J].
Wang, Jingrui ;
Ling, Sunbin ;
Ni, Jie ;
Wan, Yafeng .
BMC CANCER, 2022, 22 (01)